AI-Powered Breakthrough in Tongkat AliExtract Stabilization
Blue Eyes Biotech CO., Ltd. hassuccessfully applied deep learning algorithms to solve the industry's biggestchallenge: eurycomanone degradation in Tongkat Ali (Eurycoma longifolia)extracts. Our PredictStable™ AI model analyzed 2,347 formulation variables todevelop an optimized stabilization system that maintains:
• 98%eurycomanone content after 12 months at 25°C (vs. 62% in conventionalextracts)
• 40% improvedbioavailability through enhanced solubility
• Zerosynthetic preservatives – 100% plant-derived stabilization
Technical Highlights:
✔ Standardized to 2% eurycomanone with<5% batch variation
✔ Dual encapsulation technology protectsagainst heat and humidity
✔ Validated in 3 delivery systems:
-Softgel capsules
-Powdered supplements
-Functional beverage applications
Clinical Relevance:
- 22% greater free testosterone support vs.unstabilized extracts (6-week trial)
- 2-hour faster absorption (Tmax reduction)confirmed in pharmacokinetic study
"Our AI model identified unexpectedsynergies between rosemary antioxidants and specific phospholipids,"reveals Dr. Rajiv Menon, our Director of Computational Botany.
For Responsible Manufacturers:
- Available as ready-to-use complexes(TongkatActive™ ST-20)
- Custom standardization levels (1%-5%eurycomanone)
- Complete stability dossierincluding:
-ICH accelerated aging tests
-Photostability reports
-Heavy metal compliance certificates
Download White Paper & RequestSamples: